Colorectal cancer clinical trials
1,776 studies are looking for volunteers right now. Search near you to see which are close by and who can take part.
Or see all colorectal cancer studies in TrialFinder. Live data from ClinicalTrials.gov, updated daily.
At a glance
Where the studies are
U.S. states with the most recruiting colorectal cancer studies. A study counts once in each state where it has a site.
- Texas227
- California215
- New York177
- Florida164
- Michigan115
- Pennsylvania114
- Massachusetts112
- Tennessee110
- Virginia109
- Ohio108
- Illinois94
- Missouri88
Also in China (525), France (162), Italy (149), Spain (137), United Kingdom (101), Canada (100), Germany (97), Netherlands (82).
Types of study
Phases 1 to 4 test medicines, from first safety checks to long-term follow-up after approval. Trials of devices and programs have no phase. Observational studies give no study treatment.
- Early phase 119
- Phase 1193
- Phase 1 / Phase 2154
- Phase 2323
- Phase 2 / Phase 327
- Phase 3118
- Phase 417
- No phase (devices, programs)494
- Observational431
Recently updated studies
Recruiting colorectal cancer studies whose listing changed most recently. Open one in TrialFinder to check if you might qualify.
- RecruitingPhase 2NCT07896681
Toripalimab Plus Cetuximab and Irinotecan for Second-Line Right-Sided RAS/BRAF Wild-Type Advanced Colon Cancer Phase II Study
Ages 18 Years and over · Beijing, Beijing Municipality · Cancer Institute and Hospital, Chinese Academy of Medical Sciences
- RecruitingPhase 2NCT07564466
A Study of SKB571 in Participants With Gastrointestinal Tumors
Ages 18 Years – 75 Years · Chongqing, Chongqing Municipality · Fuzhou, Fujian +19 more · Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
- RecruitingPhase 2NCT07415031
A Solid Tumor Study for Long Term Treatment of Cancer Patients Who Participated in Adagrasib Studies
Ages 18 Years and over · Phoenix, Arizona · Bellflower, California +90 more · Mirati Therapeutics Inc.
- RecruitingPhase 2NCT06820463
A Study to Evaluate the Adverse Events, and Efficacy of Intravenous (IV) of Telisotuzumab Adizutecan in Combination With IV Oxaliplatin, Fluorouracil, Folinic Acid/Leucovorin, Bevacizumab, Panitumumab in Adult Participants With Metastatic Colorectal Cancer
Ages 18 Years and over · Duarte, California · Santa Monica, California +75 more · AbbVie
- RecruitingPhase 1NCT07213791
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
Ages 18 Years and over · Newport Beach, California · Stanford, California +24 more · Eli Lilly and Company
- RecruitingPhase 2NCT07808151
Neoadjuvant Pembrolizumab and Porustobart in Resectable pMMR/MSS Colon Cancer
Ages 18 Years and over · Los Angeles, California · Tampa, Florida +26 more · Solstice Oncology, Inc.
- RecruitingNo phase (devices, programs)NCT04144907
Protein Needs Study
Ages 45 Years – 80 Years · Edmonton, Alberta · University of Alberta
- RecruitingPhase 3NCT03486873
Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)
Ages 18 Years and over · Tucson, Arizona · Bakersfield, California +544 more · Merck Sharp & Dohme LLC
Worth knowing
- Taking part is your choice, and you can stop at any time.
- Each study has rules about who can join. The study team checks them with you before you start.
- Talk to your doctor about whether a study is a good fit for you.